[Advances in the studies of pancreatic kininogenase in male reproduction].

With the increasing attention to the relationship between male reproductive system diseases and microcirculation disorders, pancreatic kininogenase, a drug to improve microcirculation, is becoming a focus in the studies of the treatment of male reproductive diseases. It is reported recently that pancreatic kininogenase has a similar effect to type-5 phosphodiesterase inhibitors and may become a new drug for the treatment of ED. This article mainly discusses the possible action mechanisms of pancreatic kininogenase from the aspects of kallikrein-kinin system and pancreatic kininogenase promoting semen liquefaction and improving sperm quality and erectile function.